2008
FOUNDED
110X
EBBU, SEED TO $330M CANOPY GROWTH ACQUISITION
$43M
ANTHARIS THERAPEUTICS RECAPITALIZATION
11X
MYDX, SEED TO PUBLIC COMPANY
Primary Industries of Investment
Pharmaceutical / Healthcare
Advanced & Sustainable Technologies
Agriculture
Real Estate
Portfolio Companies Featured In
Our Team
Daniel Yazbeck, M.Sc.
Founder and CEO
Former Pfizer scientist. Panasonic business builder. Global CEO. Daniel Yazbeck has spent his career turning science and technology into profitable businesses. He founded Yazbeck & Co. in 2008, backed companies through exits including MyDx and Ebbu, and today leads the firm’s healthcare and technology investments. Featured in Bloomberg, CNN, VICE News, Fast Company, ABC, NBC, PBS, and CNET.
Jason Laba, Senior Managing Director
Lawyer by training. Dealmaker by trade. Jason Laba leads Yazbeck & Co.’s agriculture investments and has advised on transactions across Canada, the United States, and internationally. He previously worked for the Legislative Assembly of Ontario and served as CEO of Natural Stems, a medical cannabis company.
Our Mission
is to back great teams with capital and hands-on support, and create lasting value alongside them.
Active Investments
Antharis Therapeutics
Antharis Therapeutics is developing next-generation antibody-drug conjugates (ADCs) for cancer.
Elemental Biologics
Advancing Antibody Therapeutics for Inflammatory and Immune-Driven Diseases.
Tillat Pharmaceuticals
Tillat is building a trusted global brand of medicines for a large, underserved patient population.
In The News
